These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11004303)

  • 1. Iris color and cataract: the Blue Mountains Eye Study.
    Cumming RG; Mitchell P; Lim R
    Am J Ophthalmol; 2000 Aug; 130(2):237-8. PubMed ID: 11004303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iris color and incident cataract and cataract surgery: the Blue Mountains Eye Study.
    Younan C; Mitchell P; Cumming RG; Rochtchina E; Wang JJ
    Am J Ophthalmol; 2002 Aug; 134(2):273-4. PubMed ID: 12140040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOCS III versus the Oxford Clinical Cataract Classification and Grading System for the assessment of nuclear, cortical and posterior subcapsular cataract.
    Hall AB; Thompson JR; Deane JS; Rosenthal AR
    Ophthalmic Epidemiol; 1997 Dec; 4(4):179-94. PubMed ID: 9500153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study on risk factors for nuclear, cortical and posterior subcapsular cataract: The Casteldaccia Eye Study.
    Giuffrè G; Dardanoni G; Lodato G
    Acta Ophthalmol Scand; 2005 Oct; 83(5):567-73. PubMed ID: 16187994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lens Opacities Classification System.
    Chylack LT; Leske MC; Sperduto R; Khu P; McCarthy D
    Arch Ophthalmol; 1988 Mar; 106(3):330-4. PubMed ID: 3345149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. The Italian-American Cataract Study Group.
    Am J Epidemiol; 1991 Mar; 133(6):541-53. PubMed ID: 1672483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liées à l'Age.
    Delcourt C; Cristol JP; Tessier F; Léger CL; Michel F; Papoz L
    Am J Epidemiol; 2000 Mar; 151(5):497-504. PubMed ID: 10707918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractive associations with cataract: the Blue Mountains Eye Study.
    Lim R; Mitchell P; Cumming RG
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3021-6. PubMed ID: 10549667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cataract severity and morphology on the reliability of the Lens Opacities Classification System II (LOCS II).
    Maraini G; Pasquini P; Sperduto RD; Bonacini M; Carrieri MP; Corona R; Graziosi P; Tomba MC; Williams SL
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2400-3. PubMed ID: 2071351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of two photographic systems for grading cataract.
    Taylor HR; Lee JA; Wang F; Muñoz B
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):529-32. PubMed ID: 2001927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5.
    Age-Related Eye Disease Study Research Group
    Ophthalmology; 2001 Aug; 108(8):1400-8. PubMed ID: 11470690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataract associations with pinguecula and pterygium: the Blue Mountains Eye Study.
    Lim R; Mitchell P; Cumming RG
    Am J Ophthalmol; 1998 Nov; 126(5):717-9. PubMed ID: 9822237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liées à l'Age (POLA) study.
    Delcourt C; Carrière I; Ponton-Sanchez A; Lacroux A; Covacho MJ; Papoz L
    Arch Ophthalmol; 2000 Mar; 118(3):385-92. PubMed ID: 10721962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol, smoking, and cataracts: the Blue Mountains Eye Study.
    Cumming RG; Mitchell P
    Arch Ophthalmol; 1997 Oct; 115(10):1296-303. PubMed ID: 9338677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet and cataract: the Blue Mountains Eye Study.
    Cumming RG; Mitchell P; Smith W
    Ophthalmology; 2000 Mar; 107(3):450-6. PubMed ID: 10711880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower nasal distribution of cortical cataract: the Blue Mountains Eye Study.
    Rochtchina E; Mitchell P; Coroneo M; Wang JJ; Cumming RG
    Clin Exp Ophthalmol; 2001 Jun; 29(3):111-5. PubMed ID: 11446447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence and progression of lens opacities.
    Taylor HR; Muñoz B
    Aust N Z J Ophthalmol; 1991 Nov; 19(4):353-6. PubMed ID: 1789977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications and cataract. The Blue Mountains Eye Study.
    Cumming RG; Mitchell P
    Ophthalmology; 1998 Sep; 105(9):1751-8. PubMed ID: 9754187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case-control study.
    Miglior S; Marighi PE; Musicco M; Balestreri C; Nicolosi A; Orzalesi N
    Ophthalmic Epidemiol; 1994 Jun; 1(2):93-105. PubMed ID: 8790616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of vitamin supplements and cataract: the Blue Mountains Eye Study.
    Kuzniarz M; Mitchell P; Cumming RG; Flood VM
    Am J Ophthalmol; 2001 Jul; 132(1):19-26. PubMed ID: 11438049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.